Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436666 (6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436318 (2-(ethylamino)-9- methyl-6-(3-(5-methyl- 1,3,4-oxa...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436666 (6-(3-(5-((4- (dimethylamino)-4-(3- hydroxyphenyl)p...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436625 ((S)-6-(2-fluoro-4-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436621 ((S)-2-methoxy-9- methyl-6-(2-methyl- 4-(3-(methyla...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | <100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436566 ((R)-9-methyl-2- (methyl(pyridin-3- ylmethyl)amino)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436567 ((R)-9-methyl-6-(3-((3- (methylamino)-1- phenylprop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436568 ((R)-2-(((5- fluoropyridin-2- yl)methyl)(methyl) am...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436569 (2-(ethylamino)-6-(3- ((3-((2-fluoroethyl) amino)-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436571 ((R)-2-amino-9-methyl- 6-(3-((3-(methylamino)- 1-(t...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436573 (2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436574 ((S)-2-(ethylamino)-9- methyl-6-(3-(3- (methylamino...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436576 ((S)-2-amino-9-methyl- 6-(3-(3-(methylamino)- 1-(th...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436584 ((R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- (thiop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436588 ((S)-9-methyl-6-(3-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436599 ((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436603 ((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436605 (1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2- yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436606 ((S)-1-methyl-4-(4-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436607 ((S)-8-(ethylamino)-1- methyl-4-(4-(3- (methylamino...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436608 ((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436609 ((S)-8-methoxy-1- methyl-4-(4-(3- (methylamino)-1- ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436610 ((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436611 (2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436613 ((S)-1-ethyl-8- methoxy-4-(4-(3- (methylamino)-1- (...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436614 (2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1- (thi...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436615 ((S)-1-ethyl-4-(4-(3- (methylamino)-1- (thiophen-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436616 (2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(5- m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436617 ((S)-2-methoxy-9- methyl-6-(3-methyl- 4-(3-(methyla...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436618 ((S)-6-(3-fluoro-4-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436619 ((S)-9-ethyl-2- methoxy-6-(4-(3- (methylamino)-1- (...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436620 (2-methoxy-9-methyl- 6-(4-(3- (methylamino)-1-(4- m...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436622 ((S)-9-ethyl-6-(4-(3- (methylamino)-1- (thiophen-2-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436623 ((S)-9-fluoro-1- methyl-4-(4-(3- (methylamino)-1- (...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436626 ((S)-2-methoxy-9- methyl-6-(4-(3- (methylamino)-1- ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436631 (2-(ethylamino)-9- methyl-6-(3-(3- (methylamino)-1-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436641 ((S)-2-(ethylamino)-9- methyl-6-(4-(3- (methylamino...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436643 ((S)-2-(dimethylamino)- 9-methyl-6-(4-(3- (methylam...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436644 ((S)-2-amino-9-methyl- 6-(4-(3-(methylamino)- 1-(th...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436652 ((S)-2,9-dimethyl-6-(4- (3-(methylamino)-1- (thioph...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436659 (9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2- yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436660 ((S)-9-methyl-6-(4-(3- (methylamino)-1- (thiophen-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436665 (6-(3-(5-((4- (dimethylamino)-4- phenylpiperidin-1-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436389 ((R)-9-methyl-6-(3-((3- (methylamino)-1- phenylprop...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436394 (6-(3-(3- (benzylamino)propoxy) phenyl)-2- (ethylam...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436407 (6-(3-(4- ((benzylamino)methyl)- 1H-1,2,3-triazol-1...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436408 (2-(ethylamino)-9- methyl-6-(3-(4-(2- (methylamino)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436430 ((R)-2-hydroxy-9- methyl-6-(3-((3- (methylamino)-1-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436431 ((R)-2,9-dimethyl-6-(3- ((3-(methylamino)-1- phenyl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103] (Homo sapiens (Human)) | BDBM436434 ((R)-9-methyl-6-(3-((3- (methylamino)-1- (thiophen-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ESTEVE PHARMACEUTICALS, S.A. US Patent | Assay Description α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were... | US Patent US10590140 (2020) BindingDB Entry DOI: 10.7270/Q2WM1HGR | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 613 total ) | Next | Last >> |